The agreement marks MedCath’s fifth transaction since announcing in March it would consider divesting its hospital assets.
The Texsan Heart transaction is expected to close during MedCath’s second fiscal quarter of 2011, which ends March 31.
Read the release on Texsan Heart Hospital.
Read more coverage on MedCath:
– MedCath Completes Sale of Interest in Arizona Heart and Vascular Center
– MedCath Completes Sale of Heart Hospital of Austin to St. David’s
– Avera McKennan Completes Purchase of MedCath’s Stake in Avera Heart Hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
